Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update
- PMID: 15910483
- DOI: 10.1111/j.1478-3231.2005.01134.x
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update
Abstract
Background/aims: A large amount of new data on the treatment of chronic hepatitis B has become available such that the 2003 consensus statement requires revision and update.
Methods: New data were presented, discussed and debated in an expert pre-meeting to draft a revision. The revised contents were finalized after discussion in a general meeting of APASL.
Results: Conceptual background, including the efficacy and safety profile of currently available and emerging drugs, was reviewed. Nineteen recommendations were formed and unresolved issues and areas for further study were suggested.
Conclusion: The current therapy of chronic hepatitis B is modestly effective but not satisfactory. The development of new drugs and new strategies is required to further improve the outcomes of treatment.
Similar articles
-
[New recommendations about treatment of chronic virus hepatitis of Asian-Pacific Association for Studying the Liver (APASL): what changed in 2008?].Eksp Klin Gastroenterol. 2008;(6):114-5. Eksp Klin Gastroenterol. 2008. PMID: 19334435 Russian. No abstract available.
-
Selecting appropriate management strategies for chronic hepatitis B: who to treat.Am J Gastroenterol. 2006;101 Suppl 1:S7-12. doi: 10.1111/j.1572-0241.2006.00446.x. Am J Gastroenterol. 2006. PMID: 16448451 Review.
-
New hepatitis C guidelines for the Asia-Pacific region: APASL consensus statements on the diagnosis, management and treatment of hepatitis C virus infection.J Gastroenterol Hepatol. 2007 May;22(5):607-10. doi: 10.1111/j.1440-1746.2007.04969.x. J Gastroenterol Hepatol. 2007. PMID: 17444844 No abstract available.
-
European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.HIV Med. 2008 Feb;9(2):82-8. doi: 10.1111/j.1468-1293.2007.00535.x. HIV Med. 2008. PMID: 18257771
-
Antiviral therapy for chronic hepatitis B: are we doing any good to patients?J Antimicrob Chemother. 2009 Aug;64(2):223-6. doi: 10.1093/jac/dkp189. Epub 2009 May 25. J Antimicrob Chemother. 2009. PMID: 19468026 Review.
Cited by
-
Relapse rate and associated-factor of recurrence after stopping NUCs therapy with different prolonged consolidation therapy in HBeAg positive CHB patients.PLoS One. 2013 Jul 3;8(7):e68568. doi: 10.1371/journal.pone.0068568. Print 2013. PLoS One. 2013. PMID: 23844222 Free PMC article.
-
Cost of treating chronic hepatitis B: comparison of current treatment guidelines.World J Gastroenterol. 2012 Nov 14;18(42):6106-13. doi: 10.3748/wjg.v18.i42.6106. World J Gastroenterol. 2012. PMID: 23155339 Free PMC article.
-
Accuracy of a referral guideline for patients with chronic hepatitis B in primary care to select patients eligible for evaluation by a specialist.Gut. 2007 Jul;56(7):1027-8. doi: 10.1136/gut.2007.122333. Gut. 2007. PMID: 17566039 Free PMC article. No abstract available.
-
Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection.Ann Clin Microbiol Antimicrob. 2005 Sep 13;4:13. doi: 10.1186/1476-0711-4-13. Ann Clin Microbiol Antimicrob. 2005. PMID: 16159399 Free PMC article. Review.
-
A prophylactic approach for bone marrow transplantation from a hepatitis B surface antigen-positive donor.World J Gastroenterol. 2007 Feb 21;13(7):1138-40. doi: 10.3748/wjg.v13.i7.1138. World J Gastroenterol. 2007. PMID: 17373754 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
